Zobrazeno 1 - 10
of 38
pro vyhledávání: '"D, Oette"'
Autor:
Thomas C. Merigan, A Dunkler, Jan Balzarini, D Oette, J P Kleim, Irvin Winkler, J R Suarez, Mark A. Winters, Gunther Riess
Publikováno v:
The Journal of Infectious Diseases. 179:709-713
The safety and antiviral activity of the second-generation nonnucleoside inhibitor HBY 097 was investigated in asymptomatic or mildly symptomatic human immunodeficiency virus (HIV)-1-infected patients in a randomized, double-blinded, dose-escalation
Autor:
Jacob M. Rowe, D Oette, JJ Mazza, John M. Bennett, PA Cassileth, Edward A. Stadtmauer, E. Paietta, FA Hayes, JW Andersen, PH Wiernik
Publikováno v:
Blood. 86:457-462
The treatment of adult patients greater than 55 to 70 years of age with acute myelogenous leukemia (AML) is associated with a treatment-related mortality of approximately 25%. This prospective, double-blind randomized study was designed to see if the
Autor:
JM Pluda, R Yarchoan, PD Smith, N McAtee, LE Shay, D Oette, M Maha, SM Wahl, CE Myers, S Broder
Publikováno v:
Blood. 76:463-472
We investigated the effects of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) administered by the subcutaneous route, first alone and then alternating with azidothymidine (AZT), in leukopenic patients with severe human i
Autor:
J P, Kleim, M, Winters, A, Dunkler, J R, Suarez, G, Riess, I, Winkler, J, Balzarini, D, Oette, T C, Merigan
Publikováno v:
The Journal of infectious diseases. 179(3)
The safety and antiviral activity of the second-generation nonnucleoside inhibitor HBY 097 was investigated in asymptomatic or mildly symptomatic human immunodeficiency virus (HIV)-1-infected patients in a randomized, double-blinded, dose-escalation
Autor:
D. Oette, Jerrold J. Ellner, John L. Johnson, Robert S. Wallis, Christopher C. Whalen, Alphonse Okwera, Roy D. Mugerwa, Javon Jackson, P. Nsubuga
Publikováno v:
The Journal of infectious diseases. 174(4)
Macrophage activation and tumor necrosis factor-alpha (TNF-alpha) production are critical in tuberculosis immunity but may result in increased human immunodeficiency virus (HIV) expression and accelerated HIV disease progression in HIV-infected perso
Autor:
J M, Rowe, J W, Andersen, J J, Mazza, J M, Bennett, E, Paietta, F A, Hayes, D, Oette, P A, Cassileth, E A, Stadtmauer, P H, Wiernik
Publikováno v:
Blood. 86(2)
The treatment of adult patients greater than 55 to 70 years of age with acute myelogenous leukemia (AML) is associated with a treatment-related mortality of approximately 25%. This prospective, double-blind randomized study was designed to see if the
Autor:
HM Lazarus, J Andersen, MG Chen, D Variakojis, EG Mansour, D Oette, CA Arce, MM Oken, SL Gerson
Publikováno v:
Blood. 78(3)
Sixteen patients with relapsed non-Hodgkin's lymphoma underwent autologous bone marrow transplantation and infusion of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Treatment consisted of involved-field radiotherapy,
Autor:
J M, Pluda, R, Yarchoan, P D, Smith, N, McAtee, L E, Shay, D, Oette, M, Maha, S M, Wahl, C E, Myers, S, Broder
Publikováno v:
Blood. 76(3)
We investigated the effects of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) administered by the subcutaneous route, first alone and then alternating with azidothymidine (AZT), in leukopenic patients with severe human i
Publikováno v:
Progress in clinical and biological research. 338
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.